Swift Biosciences Raises $3M in Series A Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swift Biosciences announced on Wednesday the recent completion of a $3 million Series A financing round led by venture firm DFJ Mercury.

Also participating in the round were several unnamed Michigan-based individual investors who provided seed funding to Swift when it launched in January. The company also said that Daniel Watkins, a managing director at DFJ Mercury, is joining Swift's board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.